Technology News and Headlines

Think Bioscience Gets $55M to Unearth New Drug Pockets

Think Bioscience, a Boulder‑based biotech, announced a $55 million Series A round that was oversubscribed by investors. The capital will fund its platform that seeks previously hidden binding pockets on proteins and other molecules. By targeting these cryptic sites, the company aims to unlock novel therapeutic opportunities that traditional drug discovery misses. The raise positions Think Bioscience among the fastest‑growing AI‑driven biotech firms.